136 related articles for article (PubMed ID: 35038308)
21. An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer.
Nixon IJ; Wang LY; Migliacci JC; Eskander A; Campbell MJ; Aniss A; Morris L; Vaisman F; Corbo R; Momesso D; Vaisman M; Carvalho A; Learoyd D; Leslie WD; Nason RW; Kuk D; Wreesmann V; Morris L; Palmer FL; Ganly I; Patel SG; Singh B; Tuttle RM; Shaha AR; Gönen M; Pathak KA; Shen WT; Sywak M; Kowalski L; Freeman J; Perrier N; Shah JP
Thyroid; 2016 Mar; 26(3):373-80. PubMed ID: 26914539
[TBL] [Abstract][Full Text] [Related]
22. Comparison of survival rates between papillary and follicular thyroid carcinomas among 36,725 patients.
Oyer SL; Fritsch VA; Lentsch EJ
Ann Otol Rhinol Laryngol; 2014 Feb; 123(2):94-100. PubMed ID: 24574464
[TBL] [Abstract][Full Text] [Related]
23. Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival.
Lo CY; Chan WF; Lam KY; Wan KY
Ann Surg; 2005 Nov; 242(5):708-15. PubMed ID: 16244545
[TBL] [Abstract][Full Text] [Related]
24. The influence of age on disease outcome in 2015 ATA high-risk differentiated thyroid cancer patients.
van Velsen EFS; Peeters RP; Stegenga MT; van Kemenade FJ; van Ginhoven TM; Verburg FA; Visser WE
Eur J Endocrinol; 2021 Aug; 185(3):421-429. PubMed ID: 34242181
[TBL] [Abstract][Full Text] [Related]
25. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
26. Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients.
van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
Thyroid; 2019 Aug; 29(8):1073-1079. PubMed ID: 31140385
[No Abstract] [Full Text] [Related]
27. Predicting recurrence of papillary thyroid cancer using the eighth edition of the AJCC/UICC staging system.
Chereau N; Oyekunle TO; Zambeli-Ljepović A; Kazaure HS; Roman SA; Menegaux F; Sosa JA
Br J Surg; 2019 Jun; 106(7):889-897. PubMed ID: 31012500
[TBL] [Abstract][Full Text] [Related]
28. Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid Cancer.
Nixon IJ; Kuk D; Wreesmann V; Morris L; Palmer FL; Ganly I; Patel SG; Singh B; Tuttle RM; Shaha AR; Gönen M; Shah JP
Ann Surg Oncol; 2016 Feb; 23(2):410-5. PubMed ID: 26215199
[TBL] [Abstract][Full Text] [Related]
29. Assessment of age as different variable types for determining survival in differentiated thyroid cancer.
Genpeng L; Yuting S; Xinyi W; Tao W; Rixiang G; Zhihui L; Jingqiang Z; Jianyong L
Endocrine; 2022 Oct; 78(1):104-113. PubMed ID: 35921061
[TBL] [Abstract][Full Text] [Related]
30. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
[TBL] [Abstract][Full Text] [Related]
31. Age greater than 60 years portends a worse prognosis in patients with papillary thyroid cancer: should there be three age categories for staging?
Kauffmann RM; Hamner JB; Ituarte PHG; Yim JH
BMC Cancer; 2018 Mar; 18(1):316. PubMed ID: 29566662
[TBL] [Abstract][Full Text] [Related]
32. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
33. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
Lundgren CI; Hall P; Dickman PW; Zedenius J
Cancer; 2006 Feb; 106(3):524-31. PubMed ID: 16369995
[TBL] [Abstract][Full Text] [Related]
34. Global incidence and prevalence of differentiated thyroid cancer in childhood: systematic review and meta-analysis.
Moleti M; Aversa T; Crisafulli S; Trifirò G; Corica D; Pepe G; Cannavò L; Di Mauro M; Paola G; Fontana A; Calapai F; Cannavò S; Wasniewska M
Front Endocrinol (Lausanne); 2023; 14():1270518. PubMed ID: 37795368
[TBL] [Abstract][Full Text] [Related]
35. Survival in Papillary Thyroid Microcarcinoma: A Comparative Analysis Between the 7th and 8th Versions of the AJCC/UICC Staging System Based on the SEER Database.
Yang F; Zhong Q; Huang Z; Lian M; Fang J
Front Endocrinol (Lausanne); 2019; 10():10. PubMed ID: 30733707
[No Abstract] [Full Text] [Related]
36. Threshold primary tumour sizes for nodal and distant metastases in papillary and follicular thyroid cancers.
Zaman Mu; Fatima N; Sajjad Z; Akhtar J; Islam N; Masood Q; Ahmed A
Asian Pac J Cancer Prev; 2012; 13(6):2473-6. PubMed ID: 22938406
[TBL] [Abstract][Full Text] [Related]
37. How Many Papillae in Conventional Papillary Carcinoma? A Clinical Evidence-Based Pathology Study of 235 Unifocal Encapsulated Papillary Thyroid Carcinomas, with Emphasis on the Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features.
Xu B; Serrette R; Tuttle RM; Alzumaili B; Ganly I; Katabi N; Tallini G; Ghossein R
Thyroid; 2019 Dec; 29(12):1792-1803. PubMed ID: 31452453
[No Abstract] [Full Text] [Related]
38. Assessment of the prognostic value and N1b changes of the eighth TNM/AJCC staging system for differentiated thyroid carcinoma.
Zhi J; Wu Y; Hu L; Zhao J; Liu H; Ruan X; Hou X; Zhang J; Zheng X; Gao M
Int J Clin Oncol; 2020 Jan; 25(1):59-66. PubMed ID: 31414270
[TBL] [Abstract][Full Text] [Related]
39. Older patients with differentiated thyroid cancer exhibit more aggressive pathological characteristics than younger patients.
Johar J; Britton H; Wiseman SM
Can J Surg; 2020 Feb; 63(1):E69-E70. PubMed ID: 32031767
[TBL] [Abstract][Full Text] [Related]
40. Analysis of age and disease status as predictors of thyroid cancer-specific mortality using the Surveillance, Epidemiology, and End Results database.
Orosco RK; Hussain T; Brumund KT; Oh DK; Chang DC; Bouvet M
Thyroid; 2015 Jan; 25(1):125-32. PubMed ID: 25369076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
